Get started
Author

Marie Elise Boff

Observed names: M. Boff, Marie Boff
Observed institution: Vifor Pharma (Switzerland)
ORCID: 0009-0008-9009-8131
Observed ORCID: 0009-0008-9009-8131
OpenAlex ID: A5099072287
Ab1241 Design of Avacostar: a Real-world Study of Avacopan in Anca-associated Vasculitis (aav)
2024 · D.R.W. Jayne, R. Luqmani, et al. · Annals of the Rheumatic Diseases · 7
Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study
2026 · David R W Jayne, Raashid Luqmani, et al. · JMIR Research Protocols · 1
Avacopan Real-World Safety in Adults with ANCA-Associated Vasculitis: AvacoStar Interim Results
2026 · David R.W. Jayne, Raashid Ahmed Luqmani, et al. · Journal of the American Society of Nephrology
POS0542 AvacoStar, a real-world evidence study of avacopan in ANCA-associated vasculitis – baseline characteristics of initial patients
2025 · B. Hellmich, R. Luqmani, et al. · Annals of the Rheumatic Diseases
Baseline Characteristics of the First Patients in AvacoStar, a Real-World Study of Avacopan in ANCA-Associated Vasculitis
2024 · Achim Obergfell, David R.W. Jayne, et al. · Journal of the American Society of Nephrology
Works count: 5
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type